Modified Western blotting for insulin and other diabetes-associated peptide hormones

Abstract Now, the quantification of proinsulin/insulin contents within organisms tends to be evaluated only by enzyme-linked immunosorbent assay (ELISA), although assessing the adequacy of results by some quantification method is important. Remarkably, few scientific papers use detection by Western...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naoyuki Okita, Yoshikazu Higami, Fumio Fukai, Masaki Kobayashi, Miku Mitarai, Takao Sekiya, Takashi Sasaki
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dbc324fac75a4f98a85a3463a609a9d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dbc324fac75a4f98a85a3463a609a9d1
record_format dspace
spelling oai:doaj.org-article:dbc324fac75a4f98a85a3463a609a9d12021-12-02T12:32:49ZModified Western blotting for insulin and other diabetes-associated peptide hormones10.1038/s41598-017-04456-42045-2322https://doaj.org/article/dbc324fac75a4f98a85a3463a609a9d12017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04456-4https://doaj.org/toc/2045-2322Abstract Now, the quantification of proinsulin/insulin contents within organisms tends to be evaluated only by enzyme-linked immunosorbent assay (ELISA), although assessing the adequacy of results by some quantification method is important. Remarkably, few scientific papers use detection by Western blotting (WB), another immunological assay, of proinsulin/insulin. We found two problems with quantification of insulin and proinsulin by general WB: the shape of an insulin band in gel electrophoresis is distorted, and the retention potency to a blotting membrane of the peptide hormones (mainly insulin) is low. We solved the first problem by optimizing the sodium dodecyl sulfate concentration in the sample buffer and the second problem by glutaraldehyde fixation following treatment with a blocking solution for a short time. The improvements were confirmed by quantification of proinsulin/insulin in standards, MIN6c4 cell lysates, and MIN6c4 culture supernatants. Furthermore, we showed that the modified WB is applicable to other diabetes-associated peptide hormones: insulin analogs, glucagon, GLP-1s, somatostatins, ghrelins, and pancreatic polypeptide. Our data showed that the modified WB can contribute to qualitative or quantitative analyses of diabetes-associated peptides by providing analytical information based on electrophoresis, although ELISA, which is an almost exclusive method in the quantification of peptide hormones, supplies only numerical data.Naoyuki OkitaYoshikazu HigamiFumio FukaiMasaki KobayashiMiku MitaraiTakao SekiyaTakashi SasakiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Naoyuki Okita
Yoshikazu Higami
Fumio Fukai
Masaki Kobayashi
Miku Mitarai
Takao Sekiya
Takashi Sasaki
Modified Western blotting for insulin and other diabetes-associated peptide hormones
description Abstract Now, the quantification of proinsulin/insulin contents within organisms tends to be evaluated only by enzyme-linked immunosorbent assay (ELISA), although assessing the adequacy of results by some quantification method is important. Remarkably, few scientific papers use detection by Western blotting (WB), another immunological assay, of proinsulin/insulin. We found two problems with quantification of insulin and proinsulin by general WB: the shape of an insulin band in gel electrophoresis is distorted, and the retention potency to a blotting membrane of the peptide hormones (mainly insulin) is low. We solved the first problem by optimizing the sodium dodecyl sulfate concentration in the sample buffer and the second problem by glutaraldehyde fixation following treatment with a blocking solution for a short time. The improvements were confirmed by quantification of proinsulin/insulin in standards, MIN6c4 cell lysates, and MIN6c4 culture supernatants. Furthermore, we showed that the modified WB is applicable to other diabetes-associated peptide hormones: insulin analogs, glucagon, GLP-1s, somatostatins, ghrelins, and pancreatic polypeptide. Our data showed that the modified WB can contribute to qualitative or quantitative analyses of diabetes-associated peptides by providing analytical information based on electrophoresis, although ELISA, which is an almost exclusive method in the quantification of peptide hormones, supplies only numerical data.
format article
author Naoyuki Okita
Yoshikazu Higami
Fumio Fukai
Masaki Kobayashi
Miku Mitarai
Takao Sekiya
Takashi Sasaki
author_facet Naoyuki Okita
Yoshikazu Higami
Fumio Fukai
Masaki Kobayashi
Miku Mitarai
Takao Sekiya
Takashi Sasaki
author_sort Naoyuki Okita
title Modified Western blotting for insulin and other diabetes-associated peptide hormones
title_short Modified Western blotting for insulin and other diabetes-associated peptide hormones
title_full Modified Western blotting for insulin and other diabetes-associated peptide hormones
title_fullStr Modified Western blotting for insulin and other diabetes-associated peptide hormones
title_full_unstemmed Modified Western blotting for insulin and other diabetes-associated peptide hormones
title_sort modified western blotting for insulin and other diabetes-associated peptide hormones
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/dbc324fac75a4f98a85a3463a609a9d1
work_keys_str_mv AT naoyukiokita modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
AT yoshikazuhigami modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
AT fumiofukai modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
AT masakikobayashi modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
AT mikumitarai modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
AT takaosekiya modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
AT takashisasaki modifiedwesternblottingforinsulinandotherdiabetesassociatedpeptidehormones
_version_ 1718394010348814336